AP9200428A0 - Compounds for treating leukotriene-related diseases - Google Patents
Compounds for treating leukotriene-related diseasesInfo
- Publication number
- AP9200428A0 AP9200428A0 AP92/00428A AP9200428A AP9200428A0 AP 9200428 A0 AP9200428 A0 AP 9200428A0 AP 92/00428 A AP92/00428 A AP 92/00428A AP 9200428 A AP9200428 A AP 9200428A AP 9200428 A0 AP9200428 A0 AP 9200428A0
- Authority
- AP
- ARIPO
- Prior art keywords
- compounds
- related diseases
- treating leukotriene
- leukotriene
- treating
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US76271091A | 1991-09-19 | 1991-09-19 | |
US79093191A | 1991-11-12 | 1991-11-12 | |
US80959391A | 1991-12-18 | 1991-12-18 | |
US93286992A | 1992-08-20 | 1992-08-20 | |
CN93103596A CN1092409A (en) | 1991-09-19 | 1993-03-19 | The compound that is used for the treatment of leukotriene-related disease |
Publications (2)
Publication Number | Publication Date |
---|---|
AP9200428A0 true AP9200428A0 (en) | 1992-10-31 |
AP333A AP333A (en) | 1994-04-25 |
Family
ID=36809157
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
APAP/P/1992/000428A AP333A (en) | 1991-09-19 | 1992-09-17 | Phenyl-substituted pyridyl aliphatic compounds for treating leukotriene-related diseases. |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0604529A1 (en) |
JP (1) | JPH06510786A (en) |
CN (1) | CN1092409A (en) |
AP (1) | AP333A (en) |
AU (1) | AU2573592A (en) |
CA (1) | CA2119467A1 (en) |
IL (1) | IL103205A0 (en) |
MA (1) | MA22649A1 (en) |
MX (1) | MX9205358A (en) |
NZ (1) | NZ244371A (en) |
PT (1) | PT100881A (en) |
WO (1) | WO1993006085A1 (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994000433A1 (en) * | 1992-06-30 | 1994-01-06 | Smithkline Beecham Corporation | Process for making phenylthiomethylpyridinylalkenoates |
GB9313145D0 (en) * | 1993-06-25 | 1993-08-11 | Smithkline Beecham Plc | Process |
IL115420A0 (en) | 1994-09-26 | 1995-12-31 | Zeneca Ltd | Aminoheterocyclic derivatives |
EP0812194B1 (en) * | 1995-03-02 | 2000-08-16 | Smithkline Beecham Corporation | Use of substituted pyridine compounds for treating atopic dermatitis and contact dermatitis |
GB9508137D0 (en) * | 1995-04-21 | 1995-06-07 | Smithkline Beecham Plc | Formulation |
GB9602166D0 (en) | 1996-02-02 | 1996-04-03 | Zeneca Ltd | Aminoheterocyclic derivatives |
WO1997028128A1 (en) | 1996-02-02 | 1997-08-07 | Zeneca Limited | Heterocyclic compounds useful as pharmaceutical agents |
US5929096A (en) * | 1996-02-29 | 1999-07-27 | Smithkline Beecham Corporation | Method for treating atopic dermatitis and contact dermatitis |
PL331599A1 (en) * | 1996-08-14 | 1999-08-02 | Zeneca Ltd | Substituted derivatives of pyrimidine and their pharmaceutical application |
CA2265996A1 (en) * | 1996-09-26 | 1998-04-02 | Roger Aki Fujimoto | Aryl-substituted acrylamides with leukotriene b4 (ltb-4) receptor antagonist activity |
UA56197C2 (en) | 1996-11-08 | 2003-05-15 | Зенека Лімітед | Heterocyclic derivatives |
EP0966460A1 (en) | 1997-02-13 | 1999-12-29 | Zeneca Limited | Heterocyclic compounds useful as oxido-squalene cyclase inhibitors |
EP0966462B1 (en) | 1997-02-13 | 2003-06-11 | AstraZeneca AB | Heterocyclic compounds useful as oxido-squalene cyclase inhibitors |
GB9715895D0 (en) | 1997-07-29 | 1997-10-01 | Zeneca Ltd | Heterocyclic compounds |
GB9902989D0 (en) | 1999-02-11 | 1999-03-31 | Zeneca Ltd | Heterocyclic derivatives |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4056619A (en) * | 1975-09-08 | 1977-11-01 | Warner-Lambert Company | 1-Substituted-2-(2-pyridinyl)ethanone N-oxides |
US5004743A (en) * | 1987-11-25 | 1991-04-02 | Merck Frosst Canada, Inc. | Pyridyl styrene dialkanoic acids as anti-leukotriene agents |
EP0593464A1 (en) * | 1990-06-07 | 1994-04-27 | Smithkline Beecham Corporation | BENZOIC ACID DERIVATIVES and their use as LTB4 inhibitors |
-
1992
- 1992-09-01 CA CA002119467A patent/CA2119467A1/en not_active Abandoned
- 1992-09-01 WO PCT/US1992/007466 patent/WO1993006085A1/en not_active Application Discontinuation
- 1992-09-01 JP JP5506069A patent/JPH06510786A/en active Pending
- 1992-09-01 EP EP92920043A patent/EP0604529A1/en not_active Withdrawn
- 1992-09-01 AU AU25735/92A patent/AU2573592A/en not_active Abandoned
- 1992-09-08 MA MA22940A patent/MA22649A1/en unknown
- 1992-09-17 AP APAP/P/1992/000428A patent/AP333A/en active
- 1992-09-17 NZ NZ244371A patent/NZ244371A/en unknown
- 1992-09-17 IL IL103205A patent/IL103205A0/en unknown
- 1992-09-18 PT PT100881A patent/PT100881A/en not_active Application Discontinuation
- 1992-09-21 MX MX9205358A patent/MX9205358A/en unknown
-
1993
- 1993-03-19 CN CN93103596A patent/CN1092409A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
PT100881A (en) | 1993-10-29 |
MA22649A1 (en) | 1993-04-01 |
AP333A (en) | 1994-04-25 |
WO1993006085A1 (en) | 1993-04-01 |
AU2573592A (en) | 1993-04-27 |
NZ244371A (en) | 1995-11-27 |
MX9205358A (en) | 1993-07-01 |
CN1092409A (en) | 1994-09-21 |
CA2119467A1 (en) | 1993-04-01 |
IL103205A0 (en) | 1993-02-21 |
EP0604529A1 (en) | 1994-07-06 |
JPH06510786A (en) | 1994-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0714302A4 (en) | Therapeutic compounds | |
GB9127150D0 (en) | Novel treatment | |
GB9215633D0 (en) | Novel treatment | |
AP9200453A0 (en) | Medicaments for treating inflammatory conditions or for analgiesia | |
IL103205A0 (en) | Compounds for treating leukotriene-related diseases | |
GB9310199D0 (en) | Therapeutic compounds | |
GB9211148D0 (en) | Novel treatment | |
ZA914322B (en) | Pyridyl-benzoic acid derivatives for treating leukotrienerelated diseases | |
AP9400637A0 (en) | Therapeutic c compounds | |
GB9117819D0 (en) | Therapeutic compounds | |
ZA942911B (en) | Therapeutic compounds | |
AP9300527A0 (en) | Novel treatment | |
GB9203637D0 (en) | Novel treatment | |
ZA927160B (en) | Compounds for treating leukotriene-related diseases. | |
GB9214239D0 (en) | Compounds useful for treating tumours | |
GB9124541D0 (en) | Therapeutic compounds | |
GB9102376D0 (en) | Therapeutic compounds | |
GB9102341D0 (en) | Therapeutic compounds | |
GB9102340D0 (en) | Therapeutic compounds | |
GB9020266D0 (en) | Therapeutic compounds | |
GB9000691D0 (en) | Therapeutic compounds | |
GB9226526D0 (en) | Therapeutic compounds | |
GB9222934D0 (en) | Therapeutic compounds | |
GB9114335D0 (en) | Compounds useful for treating tumours | |
GB9127354D0 (en) | Agents for therapy |